Home/IPOs/BLUEJET

BLUEJET IPO

Blue Jet Healthcare Limited

IPO Doc

Start Date25-10-2023

Application Timing10am-5pm

Price Range₹329 - ₹346

Min Qty43

Min. Investment₹14147

Listing DateNA

Close Date27-10-2023

About Blue Jet Healthcare Limited

Blue Jet Healthcare is a speciality pharmaceutical and healthcare ingredients and intermediates company, offering niche products to innovator pharmaceutical companies and multinational generic pharmaceutical companies.

Since its incorporation in 1968, they have established a contract development and manufacturing organization (CDMO) business model (which provides critical ingredients to other pharma companies) in contrast media intermediates and high intensity sweeteners.

Contrast media is used in medical imaging and scans. Sweetners are used in pharma, beverages, personal care, confectionery and food industry.

Company operates in three product categories: (i) contrast media intermediates, (ii) high intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (APIs).

ABOUT THE INDUSTRY

The global pharma formulation market is estimated at USD 1,381 billion and is expected to grow at a CAGR of 5-6% to reach USD 1,700 billion by 2027.

The size of the global contrast-media formulations market is approx USD 5.9 billion and forecasted to grow at a CAGR of 6-8% between 2023-2025. Growing population and changing demographics, lifestyle diseases, rising healthcare expenditure, focus on early diagnosis and preventive care are factors for growth for this segment.

The global high-intensity sweetener market is estimated to be USD 3 billion in size and estimated to grow at a CAGR of 6% to 7% over next 5 years due to growing rate of diabetes and obesity, shifting consumer preference and rising urbanization.

Why To Invest in Blue Jet Healthcare Limited

Large manufacturer of specialty pharmaceutical and healthcare ingredients, offering niche products to global innovator pharmaceutical companies.

The IPO proceeds will not be used by the company. It will be received by the Selling Shareholders, in proportion to the Offered Shares sold by the respective Selling Shareholders as part of the Offer.

Strengths And Risks

Large Manufacturer: Blue Jet Healthcare is a large manufacturer of contrast media intermediates in India, with over 20 years experience in this segment. They supply critical ingredients to three of the largest contrast media manufacturers in the world, including GE Healthcare AS, Guerbet Group, and Bracco Imaging.

Niche Segment : Blue Jet Healthcare strategically focuses on complex chemistry categories in both the contrast media intermediate and high-intensity sweetener categories with high barriers to entry.

Long-standing Relationships: They have strong relationships with customers. They enter into annual and multi-year supply contracts providing strong predictability of order book revenue, and cashflow. More than 70% of our total sales is backed by annual or multi year contracts.

R&D Capability: They have a strong in-house govt recognised R&D centre. Over the past 50 years, they have developed over 100 products, with over 40 products commercialized.

Manufacturing Facilities: They have 3 manufacturing facilities in Maharashtra. These facilities have received accreditation from various regulatory agencies. In particular, one facility has been subject to US-FDA inspections in the FY 2018, and it received the USFDA establishment inspection report.

Geographic Concentration: They are dependent on Europe and the United States, which are regulated markets, for a significant portion of our revenue from operations. Any change in regulation can impact business.

Raw Material Sourcing: They depend on a limited number of raw material suppliers and three largest suppliers are located in China, Norway and India. Any delay or interruption in the supply or transportation of raw materials or cost increase can impact operations.

Foreign Exchange Risk: A significant portion of their total revenue from operations is denominated in currencies other than Indian Rupees, which exposes the business to forex fluctuation risk.

Government Regulations: Pharma industry is subject to extensive government regulations and if they fail to obtain or renew the required statutory licenses, permits and approvals, the business and cash flows may be adversely affected.

FAQs

What is the Blue Jet Healthcare Limited IPO? +

When will the IPO open? +

What is the lot size of the IPO? +

How to apply for an IPO? +

When will the IPO be allotted? +

When is the IPO listing date? +

E-IPO

Get In On The Action EarlyBuy cheap, earn big. Discover IPOs with the highest growth potential early and invest now through Rupeezy to earn big in the future.

Explore Other Products

Rupeezy AppAdvanced charts, advanced Option Chain, instant pay-in & pay-out,margin .Learn More

Rupeezy <> TradingViewEnjoy top-class trading experience enhanced by advanced TradingView charts.Learn More

DockPortfolio analysis, pledge holdings, apply in IPOs & download reports Learn More

Download Our Trading App

Connect With Us

Astha Credit & Securities Pvt Ltd
NSE, BSE & MCX Sebi Reg No:
INZ000187932

For any grievance contact:
grievance@rupeezy.in
0755-4268599

Membership ID:
NSE - 12227 BSE-6844 MCX - 40000
NSDL-IN303420 CDSL-94500

For cyber attack incident reporting:
gyanesh@rupeezy.in
9669695615

CIN:
U65929MP2003PTC016241

SEBI RA Registration:
INH000013332

SEBI Depository Participant Reg No:
IN-DP-611-2021

Connect With Us

Attention Investors:
1.No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. 2.KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Do not keep funds idle with the Stock Broker. Please note that your stock broker has to return the credit balance lying with them, within three working days in case you have not done any transaction within last 30 calendar days. Please note that in case of default of a Member, claim for funds and securities, without any transaction on the exchange will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Check the frequency of accounts settlement opted for. If you have opted for running account, please ensure that your broker settles your account and, in any case, not later than once in 90 days (or 30 days if you have opted for 30 days settlement). In case of declaration of trading member as defaulter, the claims of clients against such defaulter member would be subject to norms for eligibility of claims for compensation from IPF to the clients of the defaulter member. These norms are available on Exchange website at following link: https://www.nseindia.com/invest/about-defaulter-section.
Brokers are not permitted to accept transfer of securities as margin. Securities offered as margin/ collateral MUST remain in the account of the client and can be pledged to the broker only by way of ‘margin pledge’, created in the Depository system. Clients are not permitted to place any securities with the broker or associate of the broker or authorized person of the broker for any reason. Broker can take securities belonging to clients only for settlement of securities sold by the client.
Always keep your contact details viz. Mobile number/Email ID updated with the stock broker. Email and mobile number is mandatory and you must provide the same to your broker for updation in Exchange records. You must immediately take up the matter with Stock Broker/Exchange if you are not receiving the messages from Exchange/Depositories regularly.
Don't ignore any emails/SMSs received from the Exchange for trades done by you. Verify the same with the Contract notes/Statement of accounts received from your broker and report discrepancy, if any, to your broker in writing immediately and if the Stock Broker does not respond, please take this up with the Exchange/Depositories forthwith.
Check messages sent by Exchanges on a weekly basis regarding funds and securities balances reported by the trading member, compare it with the weekly statement of account sent by broker and immediately raise a concern to the exchange if you notice a discrepancy.
Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.
Sharing of trading credentials i.e. login id & passwords including OTP’s is prohibited.
Trading in leveraged products like options without proper understanding could lead to losses. Please trade at your own risk.
Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks could lead to losses.
Dealing in unsolicited tips through WhatsApp, Telegram, YouTube, Facebook, SMS, calls, etc should be avoided.
Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers should be avoided.

Awareness regarding guidelines regarding margin collection:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge
Pay 20% upfront margin of the transaction value to trade in cash market segment
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard
Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Advisory – KYC Compliance:

All investors are requested to take note that 6 KYC attributes i.e. Name, PAN, Address, Mobile Number, Email id and Income Range have been made mandatory. Investors availing custodian services will be additionally required to update the custodian details.
The last date to update KYC is on or before March 31, 2022.
Thereafter non-compliant trading accounts will be blocked for trading by the Exchange.
The non-compliant demat accounts will be frozen for debits by Depository Participant or Depository.
On submission of the necessary information to the stockbroker and updation of the same by the stockbroker in the Exchange systems and approval by the Exchange, the blocked trading accounts shall be unblocked by the Exchange on T+1 trading day.
The demat account shall be unfreezed once the investor submits the deficient KYC details and the same is captured by the depository participant in the depository system.
To ensure smooth settlement of trades, the investors are requested to ensure that both the trading and demat accounts are compliant with respect to the KYC requirement.
The investors are hereby requested to comply with the regulatory guidelines issued by Exchanges and Depositories from time to time with regard to KYC compliance and related requirements.

Disclaimer:

Investment in the securities market is subject to market risks, read all the related documents carefully before investing.
Brokerage will not exceed SEBI prescribed limit.
Please refer to the Risk Disclosure Document issued by SEBI and go through the Rights and Obligations and Do's and Don'ts issued by Stock Exchanges and Depositories before trading on the Stock Exchanges.
For commodities derivatives please note that Commodities Derivatives are highly leveraged instruments.
Before investing in the asset class consider your investment objectives, level of experience and risk appetite carefully.
Mutual fund investments are subject to market risks, read all scheme related documents carefully. Mutual Funds are not an approved product of the Exchanges and any dispute related to this will not be dealt at Exchange platform. ACSPL is a Mutual fund distributor/s registered for Mutual Funds.

Client Bank account Details:

Sr. No	Name of Bank Account	Bank Account Number	IFSC Code
1	ASTHA CREDIT AND SECURITIES P LTD - USCNBA A/c	00620340000150	HDFC0000062

*Investors are requested to note that Stock broker Astha Credit and Securities Private Limited is permitted to receive/pay money from/to investor through designated bank accounts only named as client bank accounts. Stock broker Astha Credit and Securities Private Limited is also required to disclose these client bank accounts to Stock Exchange. Hence, you are requested to use following client bank accounts only for the purpose of dealings in your trading account with us. The details of these client bank accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker.

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors. We do Pro trading.

Client registration documents in Vernacular languages: Get Documents